FDA and HHS Narrow COVID-19 Vaccine Eligibility Framework, Creating New Coverage and Access Questions for Medicaid Plans

The FDA has announced a new approval framework restricting routine COVID-19 booster recommendations to adults over 65 and individuals with risk factors, while requiring large clinical trials for approval in healthy populations. HHS Secretary Kennedy subsequently announced CDC will no longer recommend COVID vaccines for healthy children and pregnant women, though CDC's formal guidance allows vaccines for healthy children through shared decision-making and does not explicitly exclude pregnant women. These policy shifts create uncertainty for Medicaid managed care organizations around coverage obligations, particularly for CHIP enrollees and pregnant beneficiaries who represent mandatory coverage populations under federal Medicaid law.

Maternal · CHIP · Pharmacy · Managed Care

This is outside commentary from Manatt Health, not part of Medicaid Monitor's independently scored news coverage.

More from Manatt Health